These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26387544)

  • 21. Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells.
    Wu W; Ma D; Wang P; Cao L; Lu T; Fang Q; Zhao J; Wang J
    FEBS J; 2016 Mar; 283(5):834-49. PubMed ID: 26700310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.
    Rolón-Reyes K; Kucheryavykh YV; Cubano LA; Inyushin M; Skatchkov SN; Eaton MJ; Harrison JK; Kucheryavykh LY
    PLoS One; 2015; 10(6):e0131059. PubMed ID: 26098895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.
    Revuelta-López E; Castellano J; Roura S; Gálvez-Montón C; Nasarre L; Benitez S; Bayes-Genis A; Badimon L; Llorente-Cortés V
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2877-87. PubMed ID: 24072693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
    Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
    Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
    Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
    Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells.
    Datta A; Bhasin N; Kim H; Ranjan M; Rider B; Abd Elmageed ZY; Mondal D; Agrawal KC; Abdel-Mageed AB
    Cancer Lett; 2015 Jun; 362(1):25-35. PubMed ID: 25796439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipramine administration induces changes in the phosphorylation of FAK and PYK2 and modulates signaling pathways related to their activity.
    Zalewska T; Bielawski A; Stanaszek L; Wieczerzak K; Ziemka-Nałęcz M; Nalepa I
    Biochim Biophys Acta; 2016 Feb; 1860(2):424-33. PubMed ID: 26620976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
    Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A
    Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.
    Katsume A; Okigaki M; Matsui A; Che J; Adachi Y; Kishita E; Yamaguchi S; Ikeda K; Ueyama T; Matoba S; Yamada H; Matsubara H
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1084-92. PubMed ID: 21372295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.
    Park S; Lee HJ; Jeong SJ; Song HS; Kim M; Lee HJ; Lee EO; Kim DH; Ahn KS; Kim SH
    Food Chem Toxicol; 2011 Jun; 49(6):1367-72. PubMed ID: 21420464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.
    Kudo C; Yamakoshi H; Sato A; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
    Anticancer Res; 2011 Nov; 31(11):3719-26. PubMed ID: 22110192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PYK2 is an adhesion kinase in macrophages, localized in podosomes and activated by beta(2)-integrin ligation.
    Duong LT; Rodan GA
    Cell Motil Cytoskeleton; 2000 Nov; 47(3):174-88. PubMed ID: 11056520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of LD motifs by the focal adhesion targeting domains of focal adhesion kinase and proline-rich tyrosine kinase 2-beta: Insights from molecular dynamics simulations.
    Michael E; Polydorides S; Promponas VJ; Skourides P; Archontis G
    Proteins; 2020 Aug; ():. PubMed ID: 32776636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells.
    Monaghan KA; Khong T; Burns CJ; Spencer A
    Leukemia; 2011 Dec; 25(12):1891-9. PubMed ID: 21788946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
    Lyu A; Humphrey RS; Nam SH; Durham TA; Hu Z; Arasappan D; Horton TM; Ehrlich LIR
    Nat Commun; 2023 Oct; 14(1):6270. PubMed ID: 37805579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2.
    Lee SH; Yun S; Piao ZH; Jeong M; Kim DO; Jung H; Lee J; Kim MJ; Kim MS; Chung JW; Kim TD; Yoon SR; Greenberg PD; Choi I
    J Immunol; 2010 Jul; 185(2):917-28. PubMed ID: 20543098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.
    Meirson T; Samson AO; Gil-Henn H
    Drug Des Devel Ther; 2017; 11():1535-1557. PubMed ID: 28572720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity.
    Fan H; Guan JL
    J Biol Chem; 2011 May; 286(21):18573-82. PubMed ID: 21471206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NADPH oxidase activation in fibronectin adherent human neutrophils: A potential role for beta1 integrin ligation.
    Umanskiy K; Robinson C; Cave C; Williams MA; Lentsch AB; Cuschieri J; Solomkin JS
    Surgery; 2003 Aug; 134(2):378-83. PubMed ID: 12947344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.